Assessment of the HScore as a predictor of disease outcome in patients with COVID-19
Clinical Trial
[키워드] 95% CI
accompany
adjusted
assessment
calculated
children
coronavirus disease
COVID-19
cut-off
Cytokine storm
diagnosis of COVID-19
died
discharge
disease
disease severity
higher risk
hospital
Hospitalization
Hospitalized
hypercytokinemia
ICU
ICU admission
ICU care
in-hospital mortality
increase in
individual
intensive care
IQR
Logistic regression analysis
LOS
median
mortality rate
much lower
non-ICU
outcome
Patient
patients with COVID-19
predict
risk of death
SARS-coronavirus-2
secondary hemophagocytic lymphohistiocytosis
severe COVID-19
sHLH
significantly higher
statistically
survived
The severity of illness index
time
were recorded
[DOI] 10.1186/s12890-021-01706-0 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1186/s12890-021-01706-0 PMC 바로가기 [Article Type] Clinical Trial